- Licensing copies of de-identified images and reports is possible; selling identifiable health information needs each patient's authorization.
- Buyers ask for an independent Expert Determination, IRB approval or consent covering commercial use, and a documented chain of rights.
- Label and macro images, accession numbers and free text in reports carry identifiers and are cleaned first.
- Glass, blocks and tissue never leave the lab, and cases read for other hospitals need their agreement.
Can a pathology lab sell or license whole slide images and pathology reports?
Yes, as de-identified copies and where the lab controls the cases. Identifiable images and reports are protected health information, and HIPAA says that without the patient's authorization "a covered entity or business associate may not sell protected health information" (45 CFR 164.502). Properly de-identified data falls outside that rule, which is why the work starts with de-identification and rights, not with an export. AI data buyers have asked Origin for imaging with reports: CT, MRI, X-ray, and pathology slides.
The buyer's stated requirements are de-identification signed off by an independent third party under HIPAA's Expert Determination method (not by the seller); IRB approval, or patient consent that covers commercial licensing; and a clear chain of rights (who collected the data, who owns it, who can license it). These deals need that paperwork to get through. This page is general information, not legal advice.
| Record | Usually licensable? | Main condition |
|---|---|---|
| Whole slide images of the tissue | Yes, de-identified | Label and macro images removed; independent Expert Determination |
| Pathology reports and synoptic data | Yes, de-identified | Names, numbers, exact dates and free-text identifiers removed |
| Slide label and macro images | No | They can show the patient name and case number |
| Glass slides, paraffin blocks and tissue | No | They stay in the lab under CLIA retention |
| Cases read for a hospital or another lab | Only with that party's agreement | The service contract decides |
| Identifiable images and reports | Only with patient authorization | HIPAA treats a paid disclosure as a sale |
Who owns pathology glass slides, blocks and whole slide images?
Custody is clear; ownership is less so. CLIA makes the lab the keeper: "The laboratory must retain its records and, as applicable, slides, blocks, and tissues", and a lab that closes must still keep them available (42 CFR 493.1105). Who owns the material is not settled everywhere. A 2024 review found "there is a lack of established rules regarding the ownership of the tissue specimens, paraffin blocks, and slides", adding that the answer "is relative to local legislation and not a universal truth" (Cureus).
Patients keep a say over the glass. At one academic department, "Slides and blocks can be requested by an outside institution or patient as part of a patient's continuation of care"; outside requests need a "Consent for release, signed by Patient", and "Unstained slides/stained slides can be provided (blocks are not released)" (UT Southwestern). Institutions also govern reuse: one schedule says "Slides and blocks may be made available for use by the Biorepository after 10 years pending approval by the Medical Director of Anatomic Pathology" (UM System).
Scanned images and reports are the lab's records, but contracts decide who may license them. A reference lab or a pathology group that reads cases for hospitals should read each service agreement, and a cloud image system's terms, before anything is shared. See who owns patient records.
What do buyers require before licensing pathology data?
Three documents, each prepared by someone other than the buyer. HIPAA's Expert Determination method needs "A person with appropriate knowledge of and experience with generally accepted statistical and scientific principles and methods for rendering information not individually identifiable", who "determines that the risk is very small that the information could be used, alone or in combination with other reasonably available information, by an anticipated recipient to identify an individual who is a subject of the information" and "Documents the methods and results of the analysis that justify such determination" (45 CFR 164.514). HHS adds that "There is no specific professional degree or certification program for designating who is an expert at rendering health information de-identified" (HHS).
On consent, the Common Rule lets a research consent form include "A statement that the subject's biospecimens (even if identifiers are removed) may be used for commercial profit and whether the subject will or will not share in this commercial profit", and it allows "Broad consent for the storage, maintenance, and secondary research use of identifiable private information or identifiable biospecimens" (45 CFR 46.116). Read the consent forms you actually hold: consent to testing and care is not consent to commercial use.
Some research networks train models without receiving any files: the Apheris trust check explains federated training, in which the data custodian keeps the data and approves each computation.
| Requirement | What it means for a pathology lab | What to have ready |
|---|---|---|
| Independent Expert Determination | An outside expert reviews the image set, the reports and the metadata together | The expert's written report, its date and the recipient it covers |
| IRB approval or commercial consent | An IRB has approved the use, or patients consented to commercial use | The approval letter or the consent language, matched to each case |
| Chain of rights: who collected | The clinic or hospital that took each biopsy | Referring sources by year |
| Chain of rights: who owns and holds | The lab, a hospital client or a health system | Service agreements and data clauses |
| Chain of rights: who can license | The party with the right to grant a license | A signed statement of authority |
Health data licensing requirements covers the three requirements for every kind of health record.
How are slide labels and pathology reports de-identified?
Start with the pictures that are not tissue. In a scanned slide, "protected health information (PHI) may also be present in label and macro images that are captured as part of the scanning process", and "Approaches to addressing this include removing or redacting label and macro image objects, pixel-level scrubbing of burned-in text, or replacing them with de-identified surrogate images" (Journal of Pathology Informatics). DICOM's own profile says the de-identifier "should ensure that no identifying information that is burned in to the image pixel data" remains (DICOM PS3.15).
Then the numbers and the text. In DICOM pathology files the accession number serves "as the primary case-level identifier" (Journal of Pathology Informatics), and HIPAA's Safe Harbor list includes "Medical record numbers", "All elements of dates (except year) for dates directly related to an individual" and "Any other unique identifying number, characteristic, or code" (45 CFR 164.514). Every CLIA report names the patient: it must give "either the patient's name and identification number, or a unique patient identifier and identification number", plus "The name and address of the laboratory location where the test was performed" (42 CFR 493.1291). Identifiers in the narrative count too: one "must be removed regardless of its location in a record if it is recognizable as an identifier" (HHS).
- Drop or redact label and macro images; check thumbnails too.
- Replace accession and record numbers with new codes, and keep the key inside the lab.
- Shift or remove exact dates in headers, file names and report text.
- Remove names of patients, relatives, physicians and places from the report narrative and addenda.
- Check file names and folder paths, which often carry case numbers.
The detailed rules are in HIPAA de-identification.
Does CLIA retention limit what a lab can share?
It limits what leaves, not what can be copied. CLIA requires histopathology slides for at least 10 years, cytology slides for 5, blocks for 2 and pathology reports for 10 (42 CFR 493.1105). A license covers copies of images and reports, so the glass, blocks and tissue stay where they are and remain available for patient care. Older glass that was never scanned can be scanned for a project, but the slides go back into storage for the rest of their period. The digital pathology guide has the full retention table.
What does a first pathology data sample look like?
Small, de-identified and documented. A sample shows the buyer whether the cases fit and shows the lab what its archive really holds.
- List the cases by year, organ site, diagnosis and stain, and note which were read for outside clients. A data inventory template helps.
- Pick a slice the lab clearly controls, such as 50 to 200 cases from its own clinics over one or two years.
- Scan or export the slides with their reports, then remove label and macro images and code every identifier.
- Have the independent expert review the sample and record the method; gather the IRB approval or consent language that covers it.
- Write a short data dictionary: fields, stains, scanner settings, date ranges and gaps.
- Share it only under a written agreement; see what a data licensing agreement should include.
Example: a community pathology group sorts 12 years of cases (illustrative)
This is an illustration written for this page, with no real patient or company data. A fictional pathology group reads biopsies for its own clinics and, under contract, for two local hospitals. Before any outside conversation, it sorts its archive into three piles.
| Pile | Cases | Decision |
|---|---|---|
| Never | Glass, blocks and tissue; label and macro images; forensic and research-study cases with their own agreements | Excluded |
| Only after work | Cases read for the two hospitals | Held until each hospital agrees in writing |
| Ready first | Scanned cases from the group's own clinics, with final reports | Coded, reviewed by an outside expert, then cut into a 100-case sample |
Fictional example written for this page. The group also learns that two clinics used a consent form that mentions research use, so those cases are noted for the IRB step.
Common mistakes when a lab reviews slides for licensing
Most problems come from starting with an export instead of a rights check.
- Sending scans with label or macro images still attached.
- Letting the lab's own staff sign off on de-identification when the buyer asks for an independent expert.
- Assuming a consent to testing covers commercial use.
- Including cases read for a hospital without that hospital's written agreement.
- Coding the accession number in the image header but leaving it in the file name or the report.
- Offering glass slides or blocks, which must stay in the lab.
What have AI data buyers asked for from pathology labs?
AI data buyers have asked Origin for imaging with reports: CT, MRI, X-ray, and pathology slides. The pathology part is scanned slides paired with their final reports, reviewed first as a small sample.
The buyer's stated requirements are de-identification signed off by an independent third party under HIPAA's Expert Determination method (not by the seller); IRB approval, or patient consent that covers commercial licensing; and a clear chain of rights (who collected the data, who owns it, who can license it). These deals need that paperwork to get through. Before that sample is cut, label and macro images, accession numbers and report identifiers come out, and cases held for other institutions wait for their consent. Origin is an independent data partner. It helps an owner work out what they hold, which of the three requirements they already meet and what is missing; it does not perform Expert Determination or IRB review. Your organization decides what is shared and signs any license itself, and a buyer may pay Origin when a deal closes.
Does your company hold records like these? See what your data is worth.
Common questions
Can a pathology lab sell or license whole slide images and pathology reports to AI companies?
Yes, as de-identified copies and where the lab controls the cases. Buyers ask for de-identification signed off by an independent expert under HIPAA's Expert Determination method, IRB approval or patient consent that covers commercial licensing, and a clear chain of rights. Selling identifiable images or reports needs each patient's authorization. Glass slides and blocks stay in the lab, and label images come out first.
Who owns whole slide images scanned by a pathology lab?
The lab holds them as its own records, but who may license them depends on contracts and local law. Cases read for a hospital or another lab are often governed by that service agreement. Ownership of the glass, blocks and tissue themselves is not settled everywhere, and patients can request slides for continuing care. Check every agreement before sharing.
Do slide labels count as protected health information?
Often, yes. A slide label usually carries a case or accession number and may show the patient's name, and scanners photograph it as a separate label image and often in the macro image too. HIPAA treats record numbers and other unique codes as identifiers, so label and macro images are removed or redacted before any image leaves the lab.
Does a pathology lab need patient consent to license de-identified slides?
HIPAA does not require authorization for properly de-identified data, but buyers ask for more. They want IRB approval or patient consent that covers commercial licensing, along with an independent Expert Determination. The Common Rule lets consent forms tell patients that their biospecimens may be used for commercial profit, so check the forms the lab actually holds.
Can a lab send glass slides or paraffin blocks to an AI company?
No. Glass slides, blocks and tissue stay in the lab: CLIA sets retention periods for them, they remain available for patient care, and some labs do not release blocks at all. What a lab can license is de-identified copies, meaning scanned images with label images removed and coded reports, under a written agreement.
What does an Expert Determination cover for pathology images?
An Expert Determination is a written finding by a qualified expert that the risk of identifying anyone from the data is very small for the intended recipient. For pathology it should cover the images, the metadata, the report text and any linked fields together, and record the methods used. HHS says no specific degree or certification is required.
Can a reference lab license cases it read for other hospitals?
Only if its service agreements allow it or the hospitals agree in writing. The reference lab holds the slides, images and reports under CLIA, but the hospital or health system that sent the case may control how the data is used. Sort those cases into a separate pile and settle the rights before any sample is cut.
How many cases should a first pathology data sample include?
Usually a small set, on the order of 50 to 200 de-identified cases from records the lab clearly controls, with their final reports and a short data dictionary. The sample shows the buyer whether the stains, sites and diagnoses fit, and it lets the independent expert test the de-identification method before anyone talks about the full archive.
Sources and further reading
- eCFR: 45 CFR 164.502, Uses and disclosures of protected health information: general rules
- eCFR: 45 CFR 164.514, De-identification of protected health information
- HHS Office for Civil Rights: Guidance on methods for de-identification of PHI
- eCFR: 45 CFR 46.116, General requirements for informed consent (Common Rule)
- eCFR: 42 CFR 493.1105, Standard: Retention requirements (CLIA)
- eCFR: 42 CFR 493.1291, Standard: Test report (CLIA)
- The evolving role of DICOM in digital pathology, Journal of Pathology Informatics (2026)
- DICOM PS3.15 Annex E: Attribute Confidentiality Profiles
- UT Southwestern Pathology: Requests for Slides and Blocks
- University of Missouri System: Glass Specimen Slides and Paraffin Blocks (retention schedule)
- Begum, Ramalingam and Ramani, Storage, Retention, and Use of Leftover Pathology Specimens, Cureus (2024)
